News

November 22, 2019November 22, 2019

$106M Weill Family Foundation Gift Opens Research Network to Advance Neuroscience

News

A $106 million Weill Family Foundation initiative will bring together interdisciplinary researchers and clinicians at three West Coast universities in hopes of finding new treatments for brain and nervous system ... Read more

November 21, 2019November 21, 2019

ALS Candidate AT-1501 Advances to Phase 2 Studies, Anelixis Therapeutics Announces

News

Anelixis Therapeutics has completed its Phase 1 clinical trial testing AT-1501, an investigational antibody, in healthy volunteers and eight amyotrophic lateral sclerosis (ALS) patients. The company also announced it has secured ... Read more

November 20, 2019November 20, 2019

Kadimastem Seeks to Amend Protocol of its Trial Testing ALS Stem Cell Therapy AstroRx

News

Kadimastem plans to submit an amendment to the protocol of its ongoing Phase 1/2a trial in Israel assessing the use of AstroRx, an “off-the-shelf” stem cell therapy, for the ... Read more

November 19, 2019November 19, 2019

ALS Association Golden West Chapter Honors Mitsubishi Tanabe for Work into Treatments

News

The ALS Association Golden West Chapter has honored Mitsubishi Tanabe Pharma America (MTPA) with its Essey Commitment to Cures award for advancing research and trials into treatments for amyotrophic lateral sclerosis ... Read more

November 18, 2019November 18, 2019

ALS Prevalent Among Young Veterans Deployed in Post-9/11 U.S. Wars, Study Shows

News

Amyotrophic lateral sclerosis (ALS) is highly prevalent among young U.S. war veterans deployed post-9/11, particularly Air Force personnel, tactical operation officers, and health care workers, a recent study suggests. ... Read more

November 15, 2019November 15, 2019

Aquestive Licenses ALS Therapy Riluzole Oral Film to Zambon in the European Union

News

Aquestive Therapeutics has granted a development and commercialization license to Zambon Pharma for its investigational oral film formulation of riluzole as a treatment for amyotrophic lateral sclerosis (ALS) in the European ... Read more

November 14, 2019November 14, 2019

Blocking SARM1 Prevents Neuronal Degeneration in Mice and Cell Models, Study Shows

News

Small molecule inhibitors that block the activity of SARM1 — an enzyme that plays a key role in nerve cell degeneration — prevent the degeneration of axons in mice ... Read more

November 13, 2019

Rare Disease Film Festival Highlights Patient and Researcher Unity

amyotrophic lateral sclerosis (ALS), News

Rare disease-themed videos glowed on a large screen before an audience of people in wheelchairs, with crutches, and bearing oxygen tanks this Nov. 9 and 10 in San Francisco. ... Read more

November 13, 2019November 13, 2019

MRI-guided Focused Ultrasounds Can Safely Open Brain-Blood Barrier in ALS Patients, Trial Shows

News

The non-invasive delivery of ultrasound waves in a controlled, targeted manner can be safely used to open the blood-brain barrier in people with amyotrophic lateral sclerosis (ALS), giving temporary ... Read more

November 12, 2019November 12, 2019

Aural, TGen Collaborate on Trial Assessing Effects of Acupuncture on Recently Diagnosed ALS Patients

News

Aural Analytics and the Translational Genomics Research Institute (TGen) will collaborate on a new acupuncture clinical trial to assess how the treatment affects speech in people recently diagnosed with ... Read more

Pin It on Pinterest